Published in J Neurochem on May 01, 1991
Specificity of S fimbriae on recombinant Escherichia coli: preferential binding to gangliosides expressing NeuGc alpha (2-3)Gal and NeuAc alpha (2-8)NeuAc. Infect Immun (1993) 0.97
Ganglioside biochemistry. ISRN Biochem (2012) 0.89
Localization and imaging of gangliosides in mouse brain tissue sections by laserspray ionization inlet. J Lipid Res (2012) 0.86
Sialyl-lactotetra, a novel cell surface marker of undifferentiated human pluripotent stem cells. J Biol Chem (2014) 0.81
A novel approach for ganglioside structural analysis based on electrospray multiple-stage mass spectrometry. J Biomol Tech (2007) 0.78
Identification of seven new alpha2,3-sialyltransferase III, ST3Gal III, transcripts from human foetal brain. Glycoconj J (2004) 0.75
Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology (2008) 3.74
A procedure for the quantitative isolation of brain gangliosides. Biochim Biophys Acta (1980) 2.63
CD62/P-selectin recognition of myeloid and tumor cell sulfatides. Cell (1991) 2.16
Investigating genotype-phenotype relationships in Rett syndrome using an international data set. Neurology (2008) 2.10
Rabbit intestinal glycoprotein receptor for Escherichia coli heat-labile enterotoxin lacking affinity for cholera toxin. Infect Immun (1982) 2.08
Simultaneous liquid chromatographic determination of seventeen of the major monoamine neurotransmitters, precursors and metabolites. II. Assessment of human brain and cerebrospinal fluid concentrations. J Chromatogr (1987) 2.04
Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry (1994) 1.98
Krabbe disease: a galactosylsphingosine (psychosine) lipidosis. J Lipid Res (1980) 1.93
Monoclonal antibodies against gastrointestinal tumour-associated antigens isolated as monosialogangliosides. Int Arch Allergy Appl Immunol (1983) 1.67
Chemography: the art of navigating in chemical space. J Comb Chem (2001) 1.51
A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia. Neurology (1998) 1.50
Growth hormone treatment affects brain neurotransmitters and thyroxine [see comment]. Clin Endocrinol (Oxf) (1996) 1.46
Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord. Biochim Biophys Acta (1994) 1.44
Cerebrospinal fluid monoamine metabolites and atmospheric pressure. Biol Psychiatry (1996) 1.39
Human brain gangliosides: developmental changes from early fetal stage to advanced age. Biochim Biophys Acta (1989) 1.34
Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors. Acta Neurol Scand (1990) 1.29
Sendai virus receptor: proposed recognition structure based on binding to plastic-adsorbed gangliosides. Proc Natl Acad Sci U S A (1980) 1.27
Sialosyllactotetraosylceramide, a novel ganglioside antigen detected in human carcinomas by a monoclonal antibody. FEBS Lett (1985) 1.26
Structure of the major glucosamine-containing ganglioside of human tissues. J Biol Chem (1973) 1.25
The spectrum of SLC17A5-gene mutations resulting in free sialic acid-storage diseases indicates some genotype-phenotype correlation. Am J Hum Genet (2000) 1.19
Polystyrene-adsorbed gangliosides for investigation of the structure of the tetanus-toxin receptor. Eur J Biochem (1980) 1.19
Depletion of rafts in late endocytic membranes is controlled by NPC1-dependent recycling of cholesterol to the plasma membrane. J Cell Sci (2001) 1.17
Comparison of receptors for cholera and Escherichia coli enterotoxins in human intestine. Gastroenterology (1985) 1.17
Gangliosides of human, bovine and rabbit retina. Biochim Biophys Acta (1972) 1.14
Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age. Eur Neurol (1993) 1.13
Chemical structure of carcinoma ganglioside antigens defined by monoclonal antibody C-50 and some allied gangliosides of human pancreatic adenocarcinoma. Biochim Biophys Acta (1985) 1.13
Individual versus job-based health insurance: weighing the pros and cons. Health Aff (Millwood) (2000) 1.13
A sulfated glucosylceramide from rat kidney. J Biol Chem (1989) 1.10
Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample. Neurology (1999) 1.09
Separation of gangliosides on a new type of anion-exchange resin. Biochim Biophys Acta (1980) 1.08
Gangliosides as receptors for bacterial toxins and Sendai virus. Adv Exp Med Biol (1980) 1.07
Ten years' experience of bone marrow transplantation for Gaucher disease. Transplantation (1995) 1.07
Receptor ganglioside content of three hosts for Sendai virus. MDBK, HeLa, and MDCK cells. Biochim Biophys Acta (1984) 1.06
Isolation and structural determination of a novel ganglioside, a disialosylpentahexosylceramide from human brain. J Biol Chem (1973) 1.06
Antibody detection in Guillain-Barré syndrome. Ann Neurol (1990) 1.06
Blood brain barrier function in vascular dementia. Acta Neurol Scand (1990) 1.06
Characterization of the binding epitope of a monoclonal antibody to sulphatide. Biochem J (1988) 1.05
Measurement of apolipoprotein E (apoE) in cerebrospinal fluid. Neurochem Res (2000) 1.03
Membrane lipids of human peripheral nerve and spinal cord. Biochim Biophys Acta (1992) 1.03
A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality. J Neurol Neurosurg Psychiatry (1998) 1.02
Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease. Neuroreport (1994) 1.02
Recovery of severe sciatica. Spine (Phila Pa 1976) (1999) 1.02
White matter changes in normal pressure hydrocephalus and Binswanger disease: specificity, predictive value and correlations to axonal degeneration and demyelination. Acta Neurol Scand (2002) 1.01
Phosphatidylethanol formation in rat organs after ethanol treatment. Biochim Biophys Acta (1984) 1.00
Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120. Proc Natl Acad Sci U S A (1994) 1.00
Enzyme infusion therapy of the Norrbottnian (type 3) Gaucher disease. Neuropediatrics (1995) 1.00
Long-term follow-up of the first successful bone marrow transplantation in Gaucher disease. Transplantation (1988) 1.00
Updating the profile of C-terminal MECP2 deletions in Rett syndrome. J Med Genet (2009) 0.99
Evaluation of CSF biomarkers for axonal and neuronal degeneration, gliosis, and beta-amyloid metabolism in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2001) 0.99
Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease. Eur J Hum Genet (2001) 0.98
Binding of intraluminal toxin in cholera: trial of GM1 ganglioside charcoal. Lancet (1980) 0.97
The cerebrospinal fluid levels of tau, growth-associated protein-43 and soluble amyloid precursor protein correlate in Alzheimer's disease, reflecting a common pathophysiological process. Dement Geriatr Cogn Disord (2001) 0.95
Quantitative analysis of film coating in a fluidized bed process by in-line NIR spectrometry and multivariate batch calibration. Anal Chem (2000) 0.95
Characterization of glucosylceramide from plasma membranes of plant root cells. Biochim Biophys Acta (1991) 0.94
Statistical molecular design of building blocks for combinatorial chemistry. J Med Chem (2000) 0.94
Normal pressure hydrocephalus triggers intrathecal production of TNF-alpha. Neurobiol Aging (2003) 0.94
Sulfatide promotes the folding of proinsulin, preserves insulin crystals, and mediates its monomerization. Glycobiology (2001) 0.94
Protein analyses in cerebrospinal fluid. I. Influence of concentration gradients for proteins on cerebrospinal fluid/serum albumin ratio. Eur Neurol (1993) 0.94
Host cell-induced differences in O-glycosylation of herpes simplex virus gC-1. I. Structures of nonsialylated HPA- and PNA-binding carbohydrates. Virology (1987) 0.93
Lysosulfatide (galactosylsphingosine-3-O-sulfate) from metachromatic leukodystrophy and normal human brain. J Neurochem (1989) 0.93
A RCT of peer-mentoring for first-time mothers in socially disadvantaged areas (the MOMENTS Study). Arch Dis Child (2010) 0.93
Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18-88 years of age. Eur Neuropsychopharmacol (1993) 0.93
Ventricular cerebrospinal fluid neurofilament protein levels decrease in parallel with white matter pathology after shunt surgery in normal pressure hydrocephalus. Eur J Neurol (2007) 0.92
The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains. Schizophr Res (1999) 0.92
Rett syndrome: biogenic amines and metabolites in postmortem brain. Pediatr Neurol (1990) 0.92
[Alpha-mannosidosis]. Tidsskr Nor Laegeforen (1995) 0.92
The glycosphingolipid sulfatide in the islets of Langerhans in rat pancreas is processed through recycling: possible involvement in insulin trafficking. Glycobiology (2000) 0.91
Large alterations in ganglioside and neutral glycosphingolipid patterns in brains from cases with infantile neuronal ceroid lipofuscinosis/polyunsaturated fatty acid lipidosis. J Neurochem (1987) 0.91
Characterization of new gangliosides of the lactotetraose series in murine xenografts of a human glioma cell line. FEBS Lett (1986) 0.90
The occurrence of psychosine and other glycolipids in spleen and liver from the three major types of Gaucher's disease. Biochim Biophys Acta (1982) 0.90
Regulating and assessing risks of cholinesterase-inhibiting pesticides: divergent approaches and interpretations. J Toxicol Environ Health B Crit Rev (1999) 0.90
Differences in cerebrospinal fluid dynamics do not affect the levels of biochemical markers in ventricular CSF from patients with aqueductal stenosis and idiopathic normal pressure hydrocephalus. Eur J Neurol (2004) 0.90
Bone marrow stem cell-based gene transfer in a mouse model for metachromatic leukodystrophy: effects on visceral and nervous system disease manifestations. Gene Ther (2002) 0.90
Predictors of serum polychlorinated biphenyl concentrations in Anniston residents. Sci Total Environ (2014) 0.89
Clinical outcome in four children with metachromatic leukodystrophy treated by bone marrow transplantation. Bone Marrow Transplant (1996) 0.89
Structurally defined epitopes of Haemophilus ducreyi lipooligosaccharides recognized by monoclonal antibodies. Infect Immun (1997) 0.89
Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin. Diabetologia (1995) 0.89
A monoclonal antibody that precipitates the glycoprotein receptor for epidermal growth factor is directed against the human blood group H type 1 antigen. J Biol Chem (1983) 0.89
Beta-galactosylceramide increases and sulfatide decreases cytokine and chemokine production in whole blood cells. Immunol Lett (2004) 0.89
Norrbottnian type of Gaucher disease--clinical, biochemical and molecular biology aspects: successful treatment with bone marrow transplantation. Dev Neurosci (1991) 0.89
Immunoglobulin M in cerebrospinal fluid: reference values derived from 111 healthy individuals 18-88 years of age. Eur Neurol (1996) 0.88
Intrathecal synthesis of immunoglobulins in patients with Alzheimer's disease. Eur Neuropsychopharmacol (1990) 0.88
Tissue receptor for cholera exotoxin: structural requirements of G11 ganglioside in toxin binding and inactivation. Med Biol (1974) 0.88
Colorectal carcinomas have a characteristic ganglioside pattern. Med Biol (1983) 0.88
Gangliosides of human meconium - detection of a possible fetal antigen. FEBS Lett (1981) 0.88
Clinical and biochemical outcome of marrow transplantation for Gaucher disease of the Norrbottnian type. Acta Paediatr Scand (1990) 0.87
Composition of gangliosides and neutral glycosphingolipids of brain in classical Tay-Sachs and Sandhoff disease: more lyso-GM2 in Sandhoff disease? J Neurochem (1987) 0.87